Ruo-Chia Tseng

644 total citations
10 papers, 546 citations indexed

About

Ruo-Chia Tseng is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Ruo-Chia Tseng has authored 10 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Ruo-Chia Tseng's work include Cancer-related Molecular Pathways (4 papers), RNA modifications and cancer (3 papers) and Cancer-related gene regulation (3 papers). Ruo-Chia Tseng is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), RNA modifications and cancer (3 papers) and Cancer-related gene regulation (3 papers). Ruo-Chia Tseng collaborates with scholars based in Taiwan. Ruo-Chia Tseng's co-authors include Yi‐Ching Wang, Han‐Shui Hsu, Ching Tzao, Jer-Wei Chang, Jung-Ta Chen, Chih‐Yi Chen, Chuen-Ming Shih, William L. Ho, Ruo-Kai Lin and Jia-Yang Chen and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Clinical Cancer Research.

In The Last Decade

Ruo-Chia Tseng

10 papers receiving 537 citations

Peers

Ruo-Chia Tseng
Ruo-Chia Tseng
Citations per year, relative to Ruo-Chia Tseng Ruo-Chia Tseng (= 1×) peers Cateline Guérardel

Countries citing papers authored by Ruo-Chia Tseng

Since Specialization
Citations

This map shows the geographic impact of Ruo-Chia Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruo-Chia Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruo-Chia Tseng more than expected).

Fields of papers citing papers by Ruo-Chia Tseng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruo-Chia Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruo-Chia Tseng. The network helps show where Ruo-Chia Tseng may publish in the future.

Co-authorship network of co-authors of Ruo-Chia Tseng

This figure shows the co-authorship network connecting the top 25 collaborators of Ruo-Chia Tseng. A scholar is included among the top collaborators of Ruo-Chia Tseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruo-Chia Tseng. Ruo-Chia Tseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Yen, Yun, Tang‐Yuan Chu, & Ruo-Chia Tseng. (2025). Exosomal long noncoding RNAs and microRNAs in colorectal cancer. Tzu Chi Medical Journal. 37(3). 235–246. 1 indexed citations
2.
Tseng, Ruo-Chia, Jer-Wei Chang, Pei-Chen Wu, et al.. (2015). Growth-arrest-specific 7C protein inhibits tumor metastasis via the N-WASP/FAK/F-actin and hnRNP U/β-TrCP/β-catenin pathways in lung cancer. Oncotarget. 6(42). 44207–44221. 15 indexed citations
3.
Tseng, Ruo-Chia, et al.. (2010). SLIT2 Attenuation during Lung Cancer Progression Deregulates β-Catenin and E-Cadherin and Associates with Poor Prognosis. Cancer Research. 70(2). 543–551. 112 indexed citations
4.
Tseng, Ruo-Chia, et al.. (2009). Distinct HIC1-SIRT1-p53 Loop Deregulation in Lung Squamous Carcinoma and Adenocarcinoma Patients. Neoplasia. 11(8). 763–W11. 84 indexed citations
5.
Tseng, Ruo-Chia, et al.. (2008). Frequent down-regulation of hRAB37 in metastatic tumor by genetic and epigenetic mechanisms in lung cancer. Lung Cancer. 63(3). 360–367. 50 indexed citations
7.
Tseng, Ruo-Chia, Han‐Shui Hsu, Jia-Yang Chen, et al.. (2007). Epigenetic Inactivation of the Chromosomal Stability Control Genes BRCA1, BRCA2, and XRCC5 in Non–Small Cell Lung Cancer. Clinical Cancer Research. 13(3). 832–838. 98 indexed citations
8.
Hsu, Han‐Shui, Ruo-Chia Tseng, Jer-Wei Chang, et al.. (2004). CpG Island Methylation Is Responsible for p14ARF Inactivation and Inversely Correlates with p53 Overexpression in Resected Non–Small Cell Lung Cancer. Clinical Cancer Research. 10(14). 4734–4741. 33 indexed citations
9.
Wang, Yi‐Ching, Ruo-Chia Tseng, Ruo-Kai Lin, et al.. (2003). Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples. Journal of Clinical Investigation. 111(6). 887–895. 122 indexed citations
10.
Ho, William L., Jer-Wei Chang, Ruo-Chia Tseng, et al.. (2002). Loss of heterozygosity at loci of candidate tumor suppressor genes in microdissected primary non-small cell lung cancer. Cancer Detection and Prevention. 26(5). 343–349. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026